✦ LIBER ✦

No major difference in inhibitory susceptibility between CYP2C9.1 and CYP2C9.3

✍ Scribed by Tadaaki Hanatani; Tsuyoshi Fukuda; Sachi Onishi; Yoshihiko Funae; Junichi Azuma

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CYP2C9 gene and susceptibility to major

✍ LLerena, A; Berecz, R; Dorado, P; González, A P; Peñas-LLedó, E M; De la Rubia, 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 64 KB

Linkage between the CYP2C8 and CYP2C9 ge

✍ Umit Yasar; Stefan Lundgren; Erik Eliasson; Anna Bennet; Björn Wiman; Ulf de Fai 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Inhibitory effects of cytochrome P450 en

✍ Yan Pan; Kai Hung Tiong; Badrul Amini Abd-Rashid; Zakiah Ismail; Rusli Ismail; J 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 611 KB

Human CYP2C-mediated stereoselective phe

✍ Toshio Yasumori; Lai-shun Chen; Qing-hua Li; Masakazu Ueda; Toshiharu Tsuzuki; J 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 199 KB

Polymorphism of CYP2D6, CYP2C19, CYP2C9

✍ Jónrit Halling; Maria S. Petersen; Per Damkier; Flemming Nielsen; Philippe Grand 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 290 KB

Pharmacogenetics of acenocoumarol: CYP2C

✍ R. B. Saraeva; I. D. Paskaleva; E. Doncheva; C. B. Eap; V.S. Ganev 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB